99 filings
Page 3 of 5
EFFECT
qc7u9hfi3byzvegc
19 Nov 21
Notice of effectiveness
12:15am
8-K/A
7erlgcz
18 Nov 21
Departure of Directors or Certain Officers
5:03pm
CORRESP
ss49rd52daph
16 Nov 21
Correspondence with SEC
12:00am
UPLOAD
bftj0u9f5af7 du
15 Nov 21
Letter from SEC
12:00am
S-3
rodid1193abw540
12 Nov 21
Shelf registration
12:00am
8-K
zwq yyiw410
4 Nov 21
Departure of Directors or Certain Officers
4:58pm
8-K
1ik9gx2b5 tuv
26 Oct 21
SQZ Biotechnologies Announces Independent DSMB Recommendation to Advance Lead Cell Therapy Candidate into Combination
6:54am
8-K
5t5b9k7
13 Sep 21
SQZ Biotechnologies Announces First Autoimmune Disease Indication
6:53am
8-K
eqgpj29838qo mcm
2 Sep 21
Departure of Directors or Certain Officers
5:00pm
8-K/A
gcdv1i7hun5ayvmj94
29 Jul 21
Departure of Directors or Certain Officers
5:00pm
8-K
8vpw91a
1 Jul 21
SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience
5:07pm
8-K
xf0x tsey7byu0v
17 Jun 21
Submission of Matters to a Vote of Security Holders
5:18pm
8-K
q6nl tnxpjgw
4 Jun 21
Regulation FD Disclosure
8:09am
DEFA14A
cju78tf8
26 Apr 21
Additional proxy soliciting materials
5:10pm
DEF 14A
gsvvqym8g1s14eiof7cp
26 Apr 21
Definitive proxy
5:00pm
10-K
c9zff20j58
18 Mar 21
Annual report
6:31am
8-K
jgb1f49
25 Feb 21
Departure of Directors or Certain Officers
5:00pm